Protein Sciences Corporation Appoints New Board of Directors
... Directors. Drs. Manon M.J. Cox, MBA, who is Chief Operating Officer. Anders Essen-Moller, who is Chairman and founder of Sweden-based diamyd Medical AB, which is listed on NASDAQ OMX in Stockholm, Sweden. Donna R. Galluzzo, PhD., R.D., President and CEO of Homecare Management Strate...Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
Diamyd Medical AB (www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker DMYDY) STOCKHOLM, Sweden, May 3, 2007 – During a presentation made in Linkoping, Sweden at the Sweden-Seattle Diabetes Conference this past week-end, Professo...Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
... STOCKHOLM, March 4 /PRNewswire-FirstCall/ -- diamyd Medical announces today that the Swedish Medical P...als," says Elisabeth Lindner, President and CEO of diamyd Medical. "Type 1 diabetes is a life-long and very ...Act or demands made in the exchange rules. diamyd Medical AB (publ.) Linnegatan 89 B, SE-115 23 ...Diamyd(R) Study Published in Prestigious New England Journal of Medicine
... STOCKHOLM, October 9 /PRNewswire-FirstCall/ -- diamyd Medical reports that the world's most influential ...eter Zerhouni, Director of Business Development at diamyd and co-author of the article. "The material was re...ading Act or demands made in the exchange rules. diamyd Medical is a Swedish biopharmaceutical company foc...Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
... diamyd Medical AB ( http://www.omxgroup.com, OMX: DIAM B...CKHOLM, Sweden, March 19 /PRNewswire-FirstCall/ -- diamyd Medical (OMX: DIAM B)(OTC: DMYDY)announced today t...l comprise 306 new onset type 1 diabetes patients. diamyd Medical is planning to file clinical trial applica...Diamyd(R) Phase III Study Approved for Younger Patients in the US
... STOCKHOLM, June 8 /PRNewswire-FirstCall/ -- diamyd Medical reported today that the company has receiv...ewscom.com/cgi-bin/prnh/20080314/297194 ) diamyd Medical is conducting two parallel phase III studi...val is, as before, planned for spring 2011. diamyd Medical is represented at booth #2431 at the ADA's...Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement
...CKHOLM, Sweden, April 21 /PRNewswire-FirstCall/ -- diamyd Medical AB (publ) has decided on, and successfully...(R)," says Elisabeth Lindner, President and CEO of diamyd Medical. "At the same time as resources are secure...ading Act or demands made in the exchange rules. diamyd Medical is a Swedish biopharmaceutical company foc...Diamyd Gets Authorization to Begin Phase III Study in the US
... STOCKHOLM, March 14 /PRNewswire-FirstCall/ -- diamyd Medical AB ( http://www.omxgroup.com, ticker: DIA...//www.otcqx.com, ticker DMYDY). The FDA has given diamyd Medical permission to start a Phase III clinical s...ess," says Elisabeth Lindner, President and CEO of diamyd Medical. "Over the past months we have received do...